ARCADIA BIOSCIENCES, INC.

NASDAQ:RKDA
Annual Meeting

of Shareholders

MEETING DATE

09/10/2026
DEF 14A FILED
08/10/2026
PUBLISHED
08/10/2026 8:17 pm
TIME TO PUBLISH
08/12/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:RKDA · CUSIP 039014204 · CLASS common stock, par value $0.001 per share · CIK 0001469443

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

7
FOR
0
AGAINST
0
WITHHOLD
7
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect one Class II director
board
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing names Gregory D. Waller as the Board’s nominee for re-election.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve, pursuant to Nasdaq Listing Rule 5635(d), the potential issuance of our common stock upon exercise of the Series A-1 Preferred Investment Options that were sold in our private placement transaction that closed on June 12, 2026
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Approval is required for exercise of the Series A-1 Options and up to approximately $3.5 million of gross proceeds.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve the 2026 Omnibus Equity Incentive Plan
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states the 2015 Plan expired and no further awards may be made under it.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve an amendment to our amended and restated certificate of incorporation to effect a reverse stock split of our outstanding shares of common stock, if our Board of Directors in its discretion determines to effect a reverse stock split at any time before June 30, 2027, at a reverse stock split ratio ranging from 1-for-2 to 1-for-10, as determined by our Board of Directors at a later date
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states the primary goal is meeting Nasdaq’s minimum per share bid price requirement.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To approve, on a nonbinding advisory basis, the compensation of our named executive officers
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing requests an advisory vote on named executive officer compensation disclosed in the proxy statement.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
To ratify the appointment of Ramirez Jimenez International CPAs as our independent registered public accountants for the fiscal year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states there were no disagreements with Deloitte and no reportable events through March 30, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
7
To approve a proposal to adjourn the Meeting by the Chairperson of the Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are not sufficient votes in favor of the Issuance Proposal or the Reverse Split Proposal
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The proposal permits further solicitation if there are insufficient votes for the Issuance Proposal or Reverse Split Proposal.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

61aaca59c4af6636ba727f738ebf486c0eaa74505b87c55ae8b143845c20e419

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates